Blueprint for the Future - Exploring R&D Incentives

11:15 AM - 12:15 PM
Room 146A

This panel will frame the need for mechanisms, complementary to grant funding, that engage industry in global health research and development. Panelists will explore lessons learned from both past and ongoing R&D incentive design efforts (the Advance Market Commitment, the efforts of the WHO Expert Working Group on R&D Financing, and others) and discuss how this knowledge can help in designing future R&D incentives.


  • Moderator: Robert Hecht, Managing Director, Results for Development
  • Margaret Anderson, Executive Director, FasterCures
  • Don Joseph, COO, BIO Ventures for Global Health 
  • Jaykumar Menon, Senior Director, Education and Global Development, X Prize Foundation
  • Rajiv Shah, Administrator, USAID

Who's Who

Anderson_Margaret Margaret Anderson - Margaret Anderson is executive director of FasterCures/The Center for Accelerating Medical Solutions, an “action tank” working to improve the medical research system – to speed up the time it takes to get important new medicines from discovery to patients. She defines the organization’s strategic priorities and positions on key issues, develops its programmatic portfolio, and manages its operations. In her role, she helps bring sectors together to facilitate collaboration, and ensures policies are in place to promote medical progress. In 2011, the Clinical Research Forum recognized her with an award for leadership in public advocacy, a testament to the positive impact of her leadership and FasterCures’ vital role in improving the medical research system.  She is vice president of the Alliance for a Stronger FDA, and co-chairs the eHealth Initiative’s Council on Data and Research. She also is board member of the Council for American Medical Innovation, the Coalition for the Advancement of Medical Research, the Prostate Cancer Foundation Government Affairs Committee, and the Institute of Medicine’s Forum on Drug Discovery, Development and Translation.
Hecht_Robert Robert Hecht - Dr. Hecht joined the Results for Development as a Managing Director in April 2008, concurrent with the establishment of the new Institute.  He oversees a portfolio of projects analyzing policy barriers and proposing solutions related to AIDS and vaccine financing, health financing reforms to help countries move toward universal coverage, and improving research and development and access to new health technologies in developing countries.

Before coming to Results for Development, Dr. Hecht spent four years as senior vice president for Policy and Advocacy at the International AIDS Vaccine Initiative.  Prior to this, he had a 20 year tenure at the World Bank, where he occupied a number of senior posts including head of the Bank's central unit for Health, Nutrition, and Population, with oversight for global strategies, knowledge management, technical services, and partnerships; chief of operations for the Human Development Network; principal economist in the Latin America region; and member of the core team and a lead author of the 1993 World Development Report, "Investing in Health." From 1987 to 1996, Dr. Hecht was responsible for World Bank sponsored studies and projects in health, nutrition, and education in Africa and Latin America.

Dr. Hecht served as a director of the Joint United Nations Program on HIV/AIDS (UNAIDS) from 1998 to 2001, where he managed technical units based in South Africa, Cote d'Ivoire, and Thailand, and in Geneva.  He led UNAIDS efforts to present AIDS as a development and poverty issue impacting a wide range of social and economic goals and to analyze financing patterns, needs and modalities for fighting the pandemic.

Dr. Hecht is the author of more than 40 articles, book chapters, and other publications.  He received his undergraduate degree from Yale College and his doctorate from Cambridge University.
Joseph_Don Donald Joseph - Donald R. Joseph was named Chief Operating Officer (COO) for BIO Ventures for Global Health (BVGH) in April 2010. Mr. Joseph brings to the organization a wealth of experience in the biopharmaceutical industry. Before joining BVGH, he served in senior executive positions in both legal and business roles at private and publicly held biopharmaceutical companies including Renovis and Abgenix, where he played a key role in its acquisition by Amgen. He has consulted for a number of biopharmaceutical companies and previously served as COO of the Institute for OneWorld Health, a non-profit pharmaceutical company devoted to developing new and affordable medicines for neglected diseases.

Mr. Joseph has extensive business and legal experience, with more than 15 years in the biopharmaceutical industry. His industry projects have included a wide array of commercial, mergers and acquisitions, licensing, collaboration, and financing transactions, while providing business guidance for R&D, product launches, and sales and marketing. His therapeutic areas of experience include neurology, oncology, and antibody technology, as well as malaria and infectious diseases. His operations experience includes involvement with many marketed products in addition to research, preclinical, and clinical development of a number of products and technologies.

Prior to entering the biopharmaceutical industry, Mr. Joseph was an international partner in the San Francisco/Palo Alto office of Baker & McKenzie. He received his JD from the University of Texas Law School.

Jaykumar Menon - Jaykumar Menon brings to the X PRIZE Foundation a long history as an award-winning international human rights lawyer. Working with the Center for Constitutional Rights and in conjunction with community activists and private investigators, Mr. Menon has represented the
student leaders from Tiananmen Square against Li Peng, helped win a $4 billion judgment on behalf of victims of the Bosnian genocide against Radovan Karadzic and represented the family of the late Nigerian environmental activist Ken Saro-Wiwa against Royal Dutch Shell. Mr. Menon has also
represented several developing countries, including the Republic of South Africa and the head of state of a Caribbean nation, in their dealings with the international economic system.

Mr. Menon is a research fellow at the Centre for International Sustainable Development Law at McGill University and has written articles in many peer-reviewed international human rights law journals and reference books. Mr. Menon has also worked at McKinsey & Company and co-founded a
venture-funded Internet company. He is a published creative writer, and served as associate editor of a book published by McSweeney’s. Mr. Menon holds a Juris Doctor from Columbia Law School, a Master of International Affairs from the Columbia School of International and Public Affairs, and a
Bachelor of Arts from Brown University. He hopes to creatively effect large-scale positive social change.
Shah Rajiv Shah - Dr. Raj Shah was sworn in as the 16th Administrator of the United States Agency for International Development (USAID) on December 31, 2009. USAID, a U.S. Government agency, has provided economic and humanitarian assistance worldwide for almost 50 years.

Previously, Dr. Shah served as Under Secretary for Research, Education and Economics and as Chief Scientist at the U.S. Department of Agriculture, where he was responsible for safe, sustainable, competitive U.S. food and fiber system, as well as strong communities, families, and youth through integrated research, analysis, and education. At USDA, he launched the National Institute of Food and Agriculture, a new scientific institute that elevated the status and funding of agricultural research to be more in line with other major scientific groups. He also produced innovative initiatives in bio-energy, climate, global food security, childhood obesity, and food safety.

Prior to joining the Obama Administration, Shah served as director of Agricultural Development in the Global Development Program at the Bill and Melinda Gates Foundation. In his seven years with the Gates Foundation, Shah served as the Foundation's director of Strategic Opportunities and as deputy director of policy and finance for the Global Health Program. In these roles, he helped develop and launch the foundation's Global Development Program, and helped create both the Alliance for a Green Revolution in Africa, and the International Finance Facility for Immunization-an effort that raised more than $5 billion for child immunization.

Prior to joining the Gates Foundation in 2001, Shah was the health care policy advisor on the Gore 2000 presidential campaign and a member of Pennsylvania Gov. Ed Rendell's transition committee on health. He is the co-founder of Health Systems Analytics and Project IMPACT for South Asian Americans. In addition, he has served as a policy aide in the British Parliament and worked at the World Health Organization.

Originally from Detroit, Michigan, Shah earned his M.D. from the University of Pennsylvania Medical School and his Master of Science in health economics at the Wharton School of Business. He has attended the London School of Economics, is a graduate of the University of Michigan, and has published articles on health policy and global development. Shah previously served on the boards of the Alliance for a Green Revolution in Africa (AGRA), the Seattle Public Library, and the Seattle Community College District. In 2007, he was named a Young Global Leader by the World Economic Forum.

Dr. Shah is married with three children. He lives in Washington, D.C.